nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Carvedilol—GJA1—prostate cancer	0.00801	0.201	CrCbGaD
Methocarbamol—Carvedilol—HIF1A—prostate cancer	0.00607	0.153	CrCbGaD
Methocarbamol—Felbamate—CYP2E1—prostate cancer	0.00297	0.0748	CrCbGaD
Methocarbamol—Felbamate—CYP2C19—prostate cancer	0.00295	0.0741	CrCbGaD
Methocarbamol—Carvedilol—VEGFA—prostate cancer	0.00244	0.0615	CrCbGaD
Methocarbamol—Oxprenolol—ADRB2—prostate cancer	0.00244	0.0613	CrCbGaD
Methocarbamol—Alprenolol—ADRB2—prostate cancer	0.00223	0.0561	CrCbGaD
Methocarbamol—Hypotension—Conjugated Estrogens—prostate cancer	0.00207	0.00216	CcSEcCtD
Methocarbamol—Vomiting—Bicalutamide—prostate cancer	0.00204	0.00213	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—prostate cancer	0.00203	0.00212	CcSEcCtD
Methocarbamol—Rash—Bicalutamide—prostate cancer	0.00203	0.00211	CcSEcCtD
Methocarbamol—Dermatitis—Bicalutamide—prostate cancer	0.00203	0.00211	CcSEcCtD
Methocarbamol—Insomnia—Goserelin—prostate cancer	0.00202	0.00211	CcSEcCtD
Methocarbamol—Headache—Bicalutamide—prostate cancer	0.00201	0.0021	CcSEcCtD
Methocarbamol—Insomnia—Conjugated Estrogens—prostate cancer	0.002	0.00209	CcSEcCtD
Methocarbamol—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.002	0.00209	CcSEcCtD
Methocarbamol—Somnolence—Goserelin—prostate cancer	0.00199	0.00207	CcSEcCtD
Methocarbamol—Angioedema—Estradiol—prostate cancer	0.00199	0.00207	CcSEcCtD
Methocarbamol—Dysgeusia—Mitoxantrone—prostate cancer	0.00198	0.00206	CcSEcCtD
Methocarbamol—Somnolence—Conjugated Estrogens—prostate cancer	0.00197	0.00205	CcSEcCtD
Methocarbamol—Dyspepsia—Goserelin—prostate cancer	0.00197	0.00205	CcSEcCtD
Methocarbamol—Vertigo—Estradiol—prostate cancer	0.00195	0.00203	CcSEcCtD
Methocarbamol—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00195	0.00203	CcSEcCtD
Methocarbamol—Syncope—Estradiol—prostate cancer	0.00195	0.00203	CcSEcCtD
Methocarbamol—Pruritus—Ethinyl Estradiol—prostate cancer	0.00192	0.002	CcSEcCtD
Methocarbamol—Pain—Goserelin—prostate cancer	0.00191	0.00199	CcSEcCtD
Methocarbamol—Nausea—Bicalutamide—prostate cancer	0.00191	0.00199	CcSEcCtD
Methocarbamol—Loss of consciousness—Estradiol—prostate cancer	0.00191	0.00199	CcSEcCtD
Methocarbamol—Vision blurred—Mitoxantrone—prostate cancer	0.00191	0.00199	CcSEcCtD
Methocarbamol—Pain—Conjugated Estrogens—prostate cancer	0.00189	0.00197	CcSEcCtD
Methocarbamol—Felbamate—CYP3A4—prostate cancer	0.00187	0.0471	CrCbGaD
Methocarbamol—Feeling abnormal—Goserelin—prostate cancer	0.00184	0.00192	CcSEcCtD
Methocarbamol—Leukopenia—Mitoxantrone—prostate cancer	0.00181	0.00189	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—prostate cancer	0.00181	0.00189	CcSEcCtD
Methocarbamol—Dizziness—Ethinyl Estradiol—prostate cancer	0.0018	0.00187	CcSEcCtD
Methocarbamol—Flushing—Etoposide—prostate cancer	0.0018	0.00187	CcSEcCtD
Methocarbamol—Confusional state—Estradiol—prostate cancer	0.00179	0.00186	CcSEcCtD
Methocarbamol—Urticaria—Goserelin—prostate cancer	0.00178	0.00185	CcSEcCtD
Methocarbamol—Anaphylactic shock—Estradiol—prostate cancer	0.00177	0.00185	CcSEcCtD
Methocarbamol—Body temperature increased—Goserelin—prostate cancer	0.00177	0.00184	CcSEcCtD
Methocarbamol—Urticaria—Conjugated Estrogens—prostate cancer	0.00176	0.00183	CcSEcCtD
Methocarbamol—Convulsion—Mitoxantrone—prostate cancer	0.00175	0.00183	CcSEcCtD
Methocarbamol—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00175	0.00182	CcSEcCtD
Methocarbamol—Jaundice—Docetaxel—prostate cancer	0.00175	0.00182	CcSEcCtD
Methocarbamol—Shock—Estradiol—prostate cancer	0.00174	0.00182	CcSEcCtD
Methocarbamol—Conjunctivitis—Docetaxel—prostate cancer	0.00174	0.00181	CcSEcCtD
Methocarbamol—Vomiting—Ethinyl Estradiol—prostate cancer	0.00173	0.0018	CcSEcCtD
Methocarbamol—Rash—Ethinyl Estradiol—prostate cancer	0.00171	0.00178	CcSEcCtD
Methocarbamol—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00171	0.00178	CcSEcCtD
Methocarbamol—Headache—Ethinyl Estradiol—prostate cancer	0.0017	0.00177	CcSEcCtD
Methocarbamol—Jaundice—Capecitabine—prostate cancer	0.00169	0.00176	CcSEcCtD
Methocarbamol—Conjunctivitis—Capecitabine—prostate cancer	0.00169	0.00176	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—prostate cancer	0.00168	0.00174	CcSEcCtD
Methocarbamol—Confusional state—Mitoxantrone—prostate cancer	0.00167	0.00174	CcSEcCtD
Methocarbamol—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00165	0.00172	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—prostate cancer	0.00165	0.00172	CcSEcCtD
Methocarbamol—Hypersensitivity—Goserelin—prostate cancer	0.00165	0.00172	CcSEcCtD
Methocarbamol—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00163	0.0017	CcSEcCtD
Methocarbamol—Shock—Mitoxantrone—prostate cancer	0.00163	0.00169	CcSEcCtD
Methocarbamol—Nausea—Ethinyl Estradiol—prostate cancer	0.00161	0.00168	CcSEcCtD
Methocarbamol—Insomnia—Estradiol—prostate cancer	0.0016	0.00167	CcSEcCtD
Methocarbamol—Bradycardia—Capecitabine—prostate cancer	0.00158	0.00165	CcSEcCtD
Methocarbamol—Pruritus—Goserelin—prostate cancer	0.00158	0.00165	CcSEcCtD
Methocarbamol—Somnolence—Estradiol—prostate cancer	0.00158	0.00164	CcSEcCtD
Methocarbamol—Pruritus—Conjugated Estrogens—prostate cancer	0.00157	0.00163	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—prostate cancer	0.00157	0.00163	CcSEcCtD
Methocarbamol—Dyspepsia—Estradiol—prostate cancer	0.00156	0.00163	CcSEcCtD
Methocarbamol—Hypotension—Mitoxantrone—prostate cancer	0.00154	0.00161	CcSEcCtD
Methocarbamol—Ranolazine—CYP3A4—prostate cancer	0.00153	0.0384	CrCbGaD
Methocarbamol—Pain—Estradiol—prostate cancer	0.00152	0.00158	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—prostate cancer	0.00151	0.00158	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—prostate cancer	0.00151	0.00157	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—prostate cancer	0.00149	0.00155	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—prostate cancer	0.00148	0.00154	CcSEcCtD
Methocarbamol—Dizziness—Goserelin—prostate cancer	0.00148	0.00154	CcSEcCtD
Methocarbamol—Somnolence—Mitoxantrone—prostate cancer	0.00147	0.00153	CcSEcCtD
Methocarbamol—Dizziness—Conjugated Estrogens—prostate cancer	0.00147	0.00153	CcSEcCtD
Methocarbamol—Feeling abnormal—Estradiol—prostate cancer	0.00146	0.00152	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—prostate cancer	0.00146	0.00152	CcSEcCtD
Methocarbamol—Dyspepsia—Mitoxantrone—prostate cancer	0.00145	0.00151	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—prostate cancer	0.00145	0.00151	CcSEcCtD
Methocarbamol—Flushing—Capecitabine—prostate cancer	0.00144	0.0015	CcSEcCtD
Methocarbamol—Vomiting—Goserelin—prostate cancer	0.00142	0.00148	CcSEcCtD
Methocarbamol—Pain—Mitoxantrone—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Bradycardia—Prednisone—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Rash—Goserelin—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Dermatitis—Goserelin—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Vomiting—Conjugated Estrogens—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Urticaria—Estradiol—prostate cancer	0.00141	0.00147	CcSEcCtD
Methocarbamol—Body temperature increased—Estradiol—prostate cancer	0.0014	0.00146	CcSEcCtD
Methocarbamol—Headache—Goserelin—prostate cancer	0.0014	0.00146	CcSEcCtD
Methocarbamol—Rash—Conjugated Estrogens—prostate cancer	0.0014	0.00146	CcSEcCtD
Methocarbamol—Dermatitis—Conjugated Estrogens—prostate cancer	0.0014	0.00145	CcSEcCtD
Methocarbamol—Headache—Conjugated Estrogens—prostate cancer	0.00139	0.00145	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—prostate cancer	0.00139	0.00144	CcSEcCtD
Methocarbamol—Carvedilol—ADRB2—prostate cancer	0.00138	0.0346	CrCbGaD
Methocarbamol—Anaphylactic shock—Etoposide—prostate cancer	0.00137	0.00143	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—prostate cancer	0.00137	0.00143	CcSEcCtD
Methocarbamol—Feeling abnormal—Mitoxantrone—prostate cancer	0.00136	0.00142	CcSEcCtD
Methocarbamol—Nausea—Goserelin—prostate cancer	0.00133	0.00138	CcSEcCtD
Methocarbamol—Dysgeusia—Capecitabine—prostate cancer	0.00133	0.00138	CcSEcCtD
Methocarbamol—Propranolol—CYP3A5—prostate cancer	0.00132	0.0333	CrCbGaD
Methocarbamol—Nausea—Conjugated Estrogens—prostate cancer	0.00132	0.00137	CcSEcCtD
Methocarbamol—Urticaria—Mitoxantrone—prostate cancer	0.00131	0.00137	CcSEcCtD
Methocarbamol—Hypersensitivity—Estradiol—prostate cancer	0.00131	0.00136	CcSEcCtD
Methocarbamol—Body temperature increased—Mitoxantrone—prostate cancer	0.00131	0.00136	CcSEcCtD
Methocarbamol—Flushing—Prednisone—prostate cancer	0.00129	0.00134	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—prostate cancer	0.00128	0.00134	CcSEcCtD
Methocarbamol—Vision blurred—Capecitabine—prostate cancer	0.00128	0.00133	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—prostate cancer	0.00126	0.00131	CcSEcCtD
Methocarbamol—Pruritus—Estradiol—prostate cancer	0.00125	0.00131	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—prostate cancer	0.00125	0.0013	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—prostate cancer	0.00123	0.00128	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—prostate cancer	0.00122	0.00127	CcSEcCtD
Methocarbamol—Vertigo—Capecitabine—prostate cancer	0.00122	0.00127	CcSEcCtD
Methocarbamol—Hypersensitivity—Mitoxantrone—prostate cancer	0.00122	0.00127	CcSEcCtD
Methocarbamol—Syncope—Capecitabine—prostate cancer	0.00122	0.00127	CcSEcCtD
Methocarbamol—Leukopenia—Capecitabine—prostate cancer	0.00121	0.00126	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—prostate cancer	0.00121	0.00126	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—prostate cancer	0.00121	0.00126	CcSEcCtD
Methocarbamol—Carvedilol—CYP2E1—prostate cancer	0.0012	0.0301	CrCbGaD
Methocarbamol—Loss of consciousness—Capecitabine—prostate cancer	0.00119	0.00124	CcSEcCtD
Methocarbamol—Carvedilol—CYP1A1—prostate cancer	0.00118	0.0297	CrCbGaD
Methocarbamol—Jaundice—Epirubicin—prostate cancer	0.00118	0.00123	CcSEcCtD
Methocarbamol—Pain—Etoposide—prostate cancer	0.00118	0.00122	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—prostate cancer	0.00117	0.00122	CcSEcCtD
Methocarbamol—Dizziness—Estradiol—prostate cancer	0.00117	0.00122	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—prostate cancer	0.00115	0.0012	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—prostate cancer	0.00114	0.00119	CcSEcCtD
Methocarbamol—Vision blurred—Prednisone—prostate cancer	0.00114	0.00118	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—prostate cancer	0.00113	0.00118	CcSEcCtD
Methocarbamol—Vomiting—Estradiol—prostate cancer	0.00113	0.00117	CcSEcCtD
Methocarbamol—Shock—Docetaxel—prostate cancer	0.00112	0.00117	CcSEcCtD
Methocarbamol—Rash—Estradiol—prostate cancer	0.00112	0.00116	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—prostate cancer	0.00112	0.00116	CcSEcCtD
Methocarbamol—Dermatitis—Estradiol—prostate cancer	0.00112	0.00116	CcSEcCtD
Methocarbamol—Confusional state—Capecitabine—prostate cancer	0.00112	0.00116	CcSEcCtD
Methocarbamol—Headache—Estradiol—prostate cancer	0.00111	0.00116	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—prostate cancer	0.0011	0.00115	CcSEcCtD
Methocarbamol—Angioedema—Prednisone—prostate cancer	0.0011	0.00115	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—prostate cancer	0.00109	0.00114	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—prostate cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Shock—Capecitabine—prostate cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—prostate cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—prostate cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Vertigo—Prednisone—prostate cancer	0.00108	0.00113	CcSEcCtD
Methocarbamol—Syncope—Prednisone—prostate cancer	0.00108	0.00113	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—prostate cancer	0.00107	0.00111	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisone—prostate cancer	0.00106	0.0011	CcSEcCtD
Methocarbamol—Nausea—Estradiol—prostate cancer	0.00105	0.0011	CcSEcCtD
Methocarbamol—Vomiting—Mitoxantrone—prostate cancer	0.00105	0.00109	CcSEcCtD
Methocarbamol—Propranolol—ADRB2—prostate cancer	0.00105	0.0263	CrCbGaD
Methocarbamol—Convulsion—Prednisone—prostate cancer	0.00105	0.00109	CcSEcCtD
Methocarbamol—Rash—Mitoxantrone—prostate cancer	0.00104	0.00109	CcSEcCtD
Methocarbamol—Dermatitis—Mitoxantrone—prostate cancer	0.00104	0.00108	CcSEcCtD
Methocarbamol—Headache—Mitoxantrone—prostate cancer	0.00104	0.00108	CcSEcCtD
Methocarbamol—Hypotension—Capecitabine—prostate cancer	0.00103	0.00108	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—prostate cancer	0.00103	0.00108	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—prostate cancer	0.00102	0.00106	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—prostate cancer	0.00102	0.00106	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—prostate cancer	0.00101	0.00105	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—prostate cancer	0.00101	0.00105	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—prostate cancer	0.00101	0.00105	CcSEcCtD
Methocarbamol—Insomnia—Capecitabine—prostate cancer	0.001	0.00104	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisone—prostate cancer	0.000985	0.00103	CcSEcCtD
Methocarbamol—Nausea—Mitoxantrone—prostate cancer	0.000982	0.00102	CcSEcCtD
Methocarbamol—Pain—Docetaxel—prostate cancer	0.000977	0.00102	CcSEcCtD
Methocarbamol—Dyspepsia—Capecitabine—prostate cancer	0.000974	0.00101	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—prostate cancer	0.000972	0.00101	CcSEcCtD
Methocarbamol—Shock—Prednisone—prostate cancer	0.000969	0.00101	CcSEcCtD
Methocarbamol—Pain—Capecitabine—prostate cancer	0.000946	0.000985	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—prostate cancer	0.000941	0.00098	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—prostate cancer	0.000931	0.00097	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—prostate cancer	0.000925	0.000963	CcSEcCtD
Methocarbamol—Feeling abnormal—Capecitabine—prostate cancer	0.000911	0.000949	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—prostate cancer	0.000909	0.000947	CcSEcCtD
Methocarbamol—Body temperature increased—Docetaxel—prostate cancer	0.000903	0.00094	CcSEcCtD
Methocarbamol—Propranolol—CYP2C19—prostate cancer	0.000901	0.0227	CrCbGaD
Methocarbamol—Propranolol—CYP1A1—prostate cancer	0.000897	0.0226	CrCbGaD
Methocarbamol—Insomnia—Prednisone—prostate cancer	0.000891	0.000928	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—prostate cancer	0.00089	0.000927	CcSEcCtD
Methocarbamol—Urticaria—Capecitabine—prostate cancer	0.000879	0.000915	CcSEcCtD
Methocarbamol—Body temperature increased—Capecitabine—prostate cancer	0.000874	0.00091	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—prostate cancer	0.000874	0.00091	CcSEcCtD
Methocarbamol—Dyspepsia—Prednisone—prostate cancer	0.000867	0.000903	CcSEcCtD
Methocarbamol—Rash—Etoposide—prostate cancer	0.000867	0.000903	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—prostate cancer	0.000866	0.000902	CcSEcCtD
Methocarbamol—Headache—Etoposide—prostate cancer	0.000861	0.000897	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—prostate cancer	0.000855	0.000891	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—prostate cancer	0.000848	0.000883	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—prostate cancer	0.000847	0.000882	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—prostate cancer	0.000845	0.00088	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—prostate cancer	0.000842	0.000876	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—prostate cancer	0.00083	0.000864	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—prostate cancer	0.000823	0.000857	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—prostate cancer	0.000818	0.000852	CcSEcCtD
Methocarbamol—Nausea—Etoposide—prostate cancer	0.000816	0.00085	CcSEcCtD
Methocarbamol—Hypersensitivity—Capecitabine—prostate cancer	0.000815	0.000849	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisone—prostate cancer	0.000812	0.000845	CcSEcCtD
Methocarbamol—Pruritus—Docetaxel—prostate cancer	0.000808	0.000842	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—prostate cancer	0.000785	0.000817	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—prostate cancer	0.000783	0.000816	CcSEcCtD
Methocarbamol—Urticaria—Prednisone—prostate cancer	0.000783	0.000815	CcSEcCtD
Methocarbamol—Pruritus—Capecitabine—prostate cancer	0.000782	0.000815	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—prostate cancer	0.000782	0.000814	CcSEcCtD
Methocarbamol—Body temperature increased—Prednisone—prostate cancer	0.000779	0.000811	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—prostate cancer	0.000777	0.000809	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—prostate cancer	0.00077	0.000802	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—prostate cancer	0.000768	0.0008	CcSEcCtD
Methocarbamol—Shock—Epirubicin—prostate cancer	0.000758	0.000789	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—prostate cancer	0.000757	0.000788	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—prostate cancer	0.000755	0.000787	CcSEcCtD
Methocarbamol—Carvedilol—CYP3A4—prostate cancer	0.000753	0.0189	CrCbGaD
Methocarbamol—Dizziness—Capecitabine—prostate cancer	0.000731	0.000762	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—prostate cancer	0.000726	0.000756	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisone—prostate cancer	0.000726	0.000756	CcSEcCtD
Methocarbamol—Rash—Docetaxel—prostate cancer	0.00072	0.00075	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—prostate cancer	0.00072	0.00075	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—prostate cancer	0.00072	0.000749	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—prostate cancer	0.000719	0.000749	CcSEcCtD
Methocarbamol—Headache—Docetaxel—prostate cancer	0.000716	0.000745	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—prostate cancer	0.000713	0.000742	CcSEcCtD
Methocarbamol—Vomiting—Capecitabine—prostate cancer	0.000703	0.000732	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—prostate cancer	0.000701	0.00073	CcSEcCtD
Methocarbamol—Rash—Capecitabine—prostate cancer	0.000697	0.000726	CcSEcCtD
Methocarbamol—Pruritus—Prednisone—prostate cancer	0.000697	0.000726	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—prostate cancer	0.000697	0.000726	CcSEcCtD
Methocarbamol—Dermatitis—Capecitabine—prostate cancer	0.000697	0.000726	CcSEcCtD
Methocarbamol—Headache—Capecitabine—prostate cancer	0.000693	0.000722	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—prostate cancer	0.000685	0.000713	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—prostate cancer	0.000679	0.000707	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—prostate cancer	0.000678	0.000706	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—prostate cancer	0.000666	0.000694	CcSEcCtD
Methocarbamol—Pain—Epirubicin—prostate cancer	0.000659	0.000686	CcSEcCtD
Methocarbamol—Nausea—Capecitabine—prostate cancer	0.000657	0.000684	CcSEcCtD
Methocarbamol—Dizziness—Prednisone—prostate cancer	0.000651	0.000678	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—prostate cancer	0.000645	0.000671	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—prostate cancer	0.000635	0.000661	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—prostate cancer	0.000634	0.00066	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—prostate cancer	0.000628	0.000654	CcSEcCtD
Methocarbamol—Vomiting—Prednisone—prostate cancer	0.000626	0.000652	CcSEcCtD
Methocarbamol—Rash—Prednisone—prostate cancer	0.000621	0.000647	CcSEcCtD
Methocarbamol—Dermatitis—Prednisone—prostate cancer	0.000621	0.000646	CcSEcCtD
Methocarbamol—Headache—Prednisone—prostate cancer	0.000617	0.000643	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—prostate cancer	0.000612	0.000637	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—prostate cancer	0.00061	0.000635	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—prostate cancer	0.000609	0.000634	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—prostate cancer	0.000587	0.000612	CcSEcCtD
Methocarbamol—Nausea—Prednisone—prostate cancer	0.000585	0.000609	CcSEcCtD
Methocarbamol—Propranolol—CYP3A4—prostate cancer	0.000573	0.0144	CrCbGaD
Methocarbamol—Hypersensitivity—Epirubicin—prostate cancer	0.000568	0.000591	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—prostate cancer	0.000566	0.00059	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—prostate cancer	0.000564	0.000587	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—prostate cancer	0.000545	0.000568	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—prostate cancer	0.000525	0.000547	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—prostate cancer	0.00051	0.000531	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—prostate cancer	0.000504	0.000525	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—prostate cancer	0.00049	0.00051	CcSEcCtD
Methocarbamol—Rash—Epirubicin—prostate cancer	0.000486	0.000506	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—prostate cancer	0.000485	0.000505	CcSEcCtD
Methocarbamol—Headache—Epirubicin—prostate cancer	0.000483	0.000503	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—prostate cancer	0.000471	0.000491	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—prostate cancer	0.000458	0.000477	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—prostate cancer	0.000453	0.000472	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—prostate cancer	0.00045	0.000468	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—prostate cancer	0.000449	0.000468	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—prostate cancer	0.000447	0.000465	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—prostate cancer	0.000423	0.000441	CcSEcCtD
